|
|
|
Volumn 110 Suppl 3A, Issue , 2001, Pages
|
|
Introduction. The role of COX-2-specific inhibitors in clinical practice.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CYCLOOXYGENASE 2;
CYCLOOXYGENASE 2 INHIBITOR;
ISOENZYME;
MEMBRANE PROTEIN;
NONSTEROID ANTIINFLAMMATORY AGENT;
PROSTAGLANDIN SYNTHASE;
PROSTAGLANDIN SYNTHASE INHIBITOR;
PTGS2 PROTEIN, HUMAN;
ARTHRITIS;
ARTICLE;
CHEMICALLY INDUCED DISORDER;
DRUG ANTAGONISM;
EVIDENCE BASED MEDICINE;
GASTROINTESTINAL DISEASE;
HUMAN;
PATIENT SELECTION;
PHYSIOLOGY;
PRACTICE GUIDELINE;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
ARTHRITIS;
CYCLOOXYGENASE 2;
CYCLOOXYGENASE 2 INHIBITORS;
CYCLOOXYGENASE INHIBITORS;
EVIDENCE-BASED MEDICINE;
GASTROINTESTINAL DISEASES;
HUMANS;
ISOENZYMES;
MEMBRANE PROTEINS;
PATIENT SELECTION;
PRACTICE GUIDELINES;
PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES;
|
|
EID: 0035911107
PISSN: 00029343
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (12)
|
|
References (0)
|
